PRQR Company Profile and Key Details
ProQR Therapeutics N.V.
PRQR Stock Price Chart
Stock Price Today
ProQR Therapeutics N.V. (PRQR) stock surged +1.35%, trading at $2.26 on NASDAQ, up from the previous close of $2.23. The stock opened at $2.23, fluctuating between $2.15 and $2.37 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Company Information
| Employees | 156 |
| Beta | 0.25 |
| Sales or Revenue | $6.38M |
| 5Y Sales Change% | -0.446% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
ProQR Therapeutics N.V. (NASDAQ: PRQR) stock price is $2.26 in the last trading session. During the trading session, PRQR stock reached the peak price of $2.37 while $2.15 was the lowest point it dropped to. The percentage change in PRQR stock occurred in the recent session was 1.35% while the dollar amount for the price change in PRQR stock was $0.03.
The NASDAQ listed PRQR is part of Biotechnology industry that operates in the broader Healthcare sector. ProQR Therapeutics N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Sheila Sponselee
Vice President & Head of People and Operations
Mr. Daniel Anton de Boer
Founder, Chief Executive Officer & Member of Management Board
Dr. Gerard Platenburg
Co-Founder & Chief Scientific Officer
Ms. Sarah Cue Kiely
Vice President of Investor Relations & Corporation Communications
Mr. Jurriaan Dekkers
Chief Financial Officer
Ms. Sandra van der Kolk
Jr. Financial Controller
Mr. Aniz Girach M.D.
Chief Medical Officer
Mr. Bart Klein
Senior Vice President of Intellectual Property
Dr. Domenico Valerio Ph.D.
Founder & Independent Chairman of Supervisory Board
Mr. Rene K. Beukema
Chief Corporation Devel. Officer, Gen. Counsel & Member of Management Board
PRQR's closing price is 38.51% higher than its 52-week low of $1.61 where as its distance from 52-week high of $4.62 is -51.73%.
Number of PRQR employees currently stands at 156.
Official Website of PRQR is: https://www.proqr.com
PRQR could be contacted at phone 318 816 67000 and can also be accessed through its website. PRQR operates from Zernikedreef 9, Leiden, 2333 Ck, Netherlands.
PRQR stock volume for the day was 332.77K shares. The average number of PRQR shares traded daily for last 3 months was 615.75K.
The market value of PRQR currently stands at $233.24M with its latest stock price at $2.26 and 103.2M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com